 Proactive Investors USA & Canada | Spectrum Pharmaceuticals Announces Outstanding ZEVALIN(R ... MarketWatch (press release) The ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on the ... Spectrum Pharmaceuticals Announces Outstanding ZEVALIN ... New clinical data for ZEVALIN Injection for intravenous use ... |
